Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization

Infection and Immunity

Volumn 75, Issue 10, 2007, Pages 4804-4816

  Mo, Yongkai ^a   Quanquin, Natalie M ^a   Vecino, William H ^a,g   Ranganathan, Uma Devi ^a   Tesfa, Lydia ^a   Bourn, William ^b   Derbyshire, Keith M ^c,d   Letvin, Norman L ^e   Jacobs Jr , William R ^a   Fennelly, Glenn J ^a,f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WADSWORTH CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f JACOBI MEDICAL CENTER   (United States)

^g PeerView Institute for Medical Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; DNA VACCINE; GLYCOPROTEIN GP 120; GREEN FLUORESCENT PROTEIN; HELICASE; PLASMID DNA;

ANIMAL CELL; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIUM CONJUGATION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; DNA TRANSFER; EUKARYOTE; FLUORESCENCE ACTIVATED CELL SORTER; GENE DELETION; GENE INSERTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYSIS; MAMMAL CELL; MICROSCOPY; MONOCYTE; MOUSE; MUTANT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPLICON; SPLEEN CELL; TRANSGENE;

ANIMALS; BACTERIAL VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HIV ENVELOPE PROTEIN GP120; HUMANS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; PLASMIDS; TRANSFORMATION, GENETIC; VACCINATION; VACCINES, DNA;

EID: 34848878350     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01877-06     Document Type: Article

References (49)

1. Anonymous. 1994. Expanded programme on immunization. Global Advisory Group - part I. Wkly. Epidemiol. Rec. 69:21-27.
2. Basu, A., S. Chatterjee, and S. K. Das Gupta. 2004. Translational coupling to an upstream gene promotes folding of the mycobacterial plasmid pAL5000 replication protein RepB and thereby its origin binding activity. J. Bacteriol. 186:335-342.
3. Basu, A., M. Chawla-Sarkar, S. Chakrabarti, and S. K. Das Gupta. 2002. Origin binding activity of the mycobacterial plasmid pAL5000 replication protein RepB is stimulated through interactions with host factors and coupled expression of repA. J. Bacteriol. 184:2204-2214.
4. Bourn, W. A., Y. Jansen, H. Stutz, R. M. Warren, A. L. Williamson, and P. D. van Helden. Creation and characterization of a high-copy-number version of the pAL5000 mycobacterial replicon. Tuberculosis, in press.
5. Brodin, P., I. Rosenkrands, P. Andersen, S. T. Cole, and R. Brosch. 2004. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12:500-508.
6. + T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. J. Virol. 80:1645-1652.
7. Darji, A., C. A. Guzman, B. Gerstel, P. Wachholz, K. N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss. 1997. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91:765-775.
8. DiGiuseppe Champion, P. A., and J. S. Cox. 2007. Protein secretion systems in mycobacteria. Cell. Microbiol. 9:1376-1384.
9. Etchart, N., R. Buckland, M. A. Liu, T. F. Wild, and D. Kaiserlian. 1997. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78:1577-1580.
10. Fennelly, G. J., J. L. Flynn, V. ter Meulen, U. G. Liebert, and B. R. Bloom. 1995. Recombinant bacille Calmette-Guerin priming against measles. J. Infect. Dis. 172:698-705.
11. Fennelly, G. J., S. A. Khan, M. A. Abadi, T. F. Wild, and B. R. Bloom. 1999. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162:1603-1610.
12. Flint, J. L., J. C. Kowalski, P. K. Karnati, and K. M. Derbyshire. 2004. The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 101:12598-12603.
13. Freund, J., M. M. Lipton, and L. R. Morrison. 1950. Demyelination in the guinea pig in chronic allergic encephalomyelitis produced by injecting guinea pig brain in oil emulsion containing a variant of Mycobacterium butyricum. Arch. Pathol. 50:108-121.
14. Freund, J., and S. H. Stone. 1959. The effectiveness of tuberculo-glycolipid as an adjuvant in eliciting allergic encephalomyelitis and aspermatogenesis. J. Immunol. 82:560-567.
15. Garbe, T. R., J. Barathi, S. Barnini, Y. Zhang, C. Abou-Zeid, D. Tang, R. Mukherjee, and D. B. Young. 1994. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133-138.
16. Grillot-Courvalin, C., S. Goussard, and P. Courvalin. 2002. Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell. Microbiol. 4:177-186.
17. Grillot-Courvalin, C., S. Goussard, F. Huetz, D. M. Ojcius, and P. Courvalin. 1998. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16:862-866.
18. Haley, J. L., D. G. Young, A. Alexandroff, K. James, and A. M. Jackson. 1999. Enhancing the immunotherapeutic potential of mycobacteria by transfection with tumour necrosis factor-alpha. Immunology 96:114-121.
19. Hamajima, K., S. Sasaki, J. Fukushima, T. Kaneko, K. Q. Xin, I. Kudoh, and K. Okuda. 1998. Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response. Clin. Immunol. Immunopathol. 88:205-210.
20. Hess, J., I. Gentschev, D. Miko, M. Welzel, C. Ladel, W. Goebel, and S. H. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458-1463.
21. + T lymphocyte induction through priming with recombinant Mycobacterium smegmatis. J. Virol. 81:74-83.
22. Ikonomidis, G., D. A. Portnoy, W. Gerhard, and Y. Paterson. 1997. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccine 15:433-440.
23. Kawahara, M., K. Matsuo, and M. Honda. 2006. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs. Clin. Immunol. 119:67-78.
24. Matano, T., M. Kobayashi, H. Igarashi, A. Takeda, H. Nakamura, M. Kano, C. Sugimoto, K. Mori, A. Iida, T. Hirata, M. Hasegawa, T. Yuasa, M. Miyazawa, Y. Takahashi, M. Yasunami, A. Kimura, D. H. O'Connor, D. I. Watkins, and Y. Nagai. 2004. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199:1709-1718.
25. Molife, R., and B. W. Hancock. 2002. Adjuvant therapy of malignant melanoma. Crit. Rev. Oncol. Hematol. 44:81-102.
26. Ota, M. O., J. Vekemans, S. E. Schlegel-Haueter, K. Fielding, M. Sanneh, M. Kidd, M. J. Newport, P. Aaby, H. Whittle, P. H. Lambert, K. P. McAdam, C. A. Siegrist, and A. Marchant. 2002. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J. Immunol. 168:919-925.
27. Parsons, L. M., C. S. Jankowski, and K. M. Derbyshire. 1998. Conjugal transfer of chromosomal DNA in Mycobacterium smegmatis. Mol. Microbiol. 28:571-582.
28. Pavelka, M. S., Jr., and W. R. Jacobs, Jr. 1996. Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis. J. Bacteriol. 178:6496-6507.
29. Pavelka, M. S., Jr., and W. R. Jacobs, Jr. 1999. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J. Bacteriol. 181:4780-4789.
30. Powell, R. J., G. K. Lewis, and D. K. Hone. 27 January 2004. Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same. U.S. patent 6682729.
31. Shen, H., J. F. Miller, X. Fan, D. Kolwyck, R. Ahmed, and J. T. Harty. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 92:535-545.
32. Shepel, M., and M. R. Klugerman. 1963. Effect of adjuvants on antibody response of rabbits inoculated with Venezuelan equine encephalomyelitis virus. J. Bacteriol. 85:1150-1155.
33. Simmons, M., K. R. Porter, C. G. Hayes, D. W. Vaughn, and R. Putnak. 2006. Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques. J. Virol. 80:9577-9585.
34. Sizemore, D. R., A. A. Branstrom, and J. C. Sadoff. 1995. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270: 299-302.
35. Sizemore, D. R., A. A. Branstrom, and J. C. Sadoff. 1997. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 15:804-807.
36. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
37. Steger, K. K., and C. D. Pauza. 1997. Immunization of Macaca mulatta with aroA attenuated Salmonella typhimurium expressing the SIVp27 antigen. J. Med. Primatol. 26:44-50.
38. Stolt, P., and N. G. Stoker. 1996. Functional definition of regions necessary for replication and incompatibility in the Mycobacterium fortuitum plasmid pAL5000. Microbiology 142:2795-2802.
39. Stolt, P., and N. G. Stoker. 1996. Protein-DNA interactions in the ori region of the Mycobacterium fortuitum plasmid pAL5000. J. Bacteriol. 178:6693-6700.
40. Stolt, P., and N. G. Stoker. 1997. Mutational analysis of the regulatory region of the Mycobacterium plasmid pAL5000. Nucleic Acids Res. 25:3840-3846.
41. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, et al. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
42. Thomsen, D. R., R. M. Stenberg, W. F. Goins, and M. F. Stinski. 1984. Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81:659-663.
43. Ugen, K. E., S. B. Nyland, J. D. Boyer, C. Vidal, L. Lera, S. Rasheid, M. Chattergoon, M. L. Bagarazzi, R. Ciccarelli, T. Higgins, Y. Baine, R. Ginsberg, R. R. Macgregor, and D. B. Weiner. 1998. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 16:1818-1821.
44. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
45. Wards, B. J., and D. M. Collins. 1996. Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol. Lett. 145:101-105.
46. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Feigner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
47. Yi, Z., Y. Fu, C. Yang, J. Li, X. Luo, Q. Chen, W. Zeng, S. Jiang, Y. Jiang, Y. He, J. Yang, Y. Liu, N. Li, and D. Y. Zhu. 2007. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice. Vaccine 25:638-648.
48. Yu, J. S., J. W. Peacock, S. Vanleeuwen, T. Hsu, W. R. Jacobs, Jr., M. J. Cayabyab, N. L. Letvin, R. Frothingham, H. F. Staats, H. X. Liao, and B. F. Haynes. 2006. Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis. Clin. Vaccine Immunol. 13:1204-1211.
49. Zhu, Y. D., G. Fennelly, C. Miller, R. Tarara, I. Saxe, B. Bloom, and M. McChesney. 1997. Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia. J Infect. Dis. 176:1445-1453.